BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 4633781)

  • 1. [Behavior of the progessive antithrombin during long-term anticoagulant therapy (Vitamin K antagonists)].
    Scheel H; Bergmann A; Wegner H
    Z Gesamte Inn Med; 1973 Feb; 28(3):38-41 passim. PubMed ID: 4633781
    [No Abstract]   [Full Text] [Related]  

  • 2. [Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases].
    Verstraete M
    Clin Ter; 1975 Jun; 73(5):403-22. PubMed ID: 1139864
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term therapy with anticoagulants].
    Remde W
    Z Gesamte Inn Med; 1973 Jan; 28(2):23-7. PubMed ID: 4632544
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anticoagulant therapy and late recurrence of myocardial infarcts].
    Schaller K
    Z Arztl Fortbild (Jena); 1974 Mar; 68(6):291-2. PubMed ID: 4421081
    [No Abstract]   [Full Text] [Related]  

  • 5. A critical evaluation of anticoagulant therapy.
    Wright IS
    Geriatrics; 1969 Mar; 24(3):96-100. PubMed ID: 4885555
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of the beta-receptor blocking agent Visken on the action of coumarin.
    Vinazzer H
    Int J Clin Pharmacol Biopharm; 1975 Dec; 12(4):458-60. PubMed ID: 1351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term anticoagulant therapy].
    Holzknecht F
    Wien Med Wochenschr; 1972 Jun; 122(23):327-34. PubMed ID: 4625299
    [No Abstract]   [Full Text] [Related]  

  • 8. [Long-term therapy and monitoring in anticoagulant therapy].
    Linke H; Schlote A
    Z Gesamte Inn Med; 1973 Jan; 28(2):31-2 contd. PubMed ID: 4632546
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical experiences with anticoagulant long term treatment of predominantly cardiologic patients].
    Kubicek F; Praschl E
    Wien Klin Wochenschr; 1968 Nov; 80(44):813-9. PubMed ID: 4974107
    [No Abstract]   [Full Text] [Related]  

  • 10. Long term anticoagulant therapy following myocardial infarction.
    Johnson DH
    Minn Med; 1976 May; 59(5):333-7. PubMed ID: 818498
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anticoagulation by oral treatment with vitamin K antagonists].
    Kemkes-Matthes B
    Hamostaseologie; 2008 Dec; 28(5):421-7. PubMed ID: 19132171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Causes of the altered Falithrom requirement following myocardial infarct].
    Schaller K
    Z Gesamte Inn Med; 1972 Sep; 27(17):756-8. PubMed ID: 4640145
    [No Abstract]   [Full Text] [Related]  

  • 13. [Functional protein S in 77 patients treated with anticoagulants and in 32 probands with normal coagulation parameters].
    Halbmayer WM; Feichtinger C; Rubi K; Fischer M
    Med Klin (Munich); 1992 Mar; 87(3):109-12, 158. PubMed ID: 1533702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term anticoagulant treatment].
    Thiroloix P; Heurtin B; Barrillon A
    Nouv Presse Med; 1978 May; 7(21):1861. PubMed ID: 673743
    [No Abstract]   [Full Text] [Related]  

  • 15. [Simultaneous oral anticoagulant and benzydamine therapy].
    Duckert F; Widmer LK; Madar G
    Schweiz Med Wochenschr; 1974 Jul; 104(30):1069-71. PubMed ID: 4215130
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombin generation test in patients under anticoagulant therapy with vitamin K antagonists.
    Brocal I; Marco P; Lucas J; Verdú J; Tarín F
    Thromb Haemost; 2009 Mar; 101(3):594-5. PubMed ID: 19277428
    [No Abstract]   [Full Text] [Related]  

  • 17. [Influence of long-term anticoagulant treatment on reinfarction, mortality and rehabilitation of patients with myocardial infarct. 4-year-observation ambulatory surveillance of infarction].
    Schubert W
    Z Gesamte Inn Med; 1972 Apr; 27(7):307-11. PubMed ID: 4625900
    [No Abstract]   [Full Text] [Related]  

  • 18. [Methods of controlling therapy with secondary-action anticoagulants].
    Kotovshchikova MA; Khanina TM
    Vrach Delo; 1973 May; 5():8-12. PubMed ID: 4593417
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical study of a new antivitamin K: 6134 M.D. 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol].
    Pernod J; Kermarec J; Migne J
    Therapie; 1968; 23(3):567-74. PubMed ID: 4906093
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of glafenin (Glifanan) on anticoagulant treatment with coumarin derivatives].
    Boeijinga JK; Bing GT; van der Meer J
    Ned Tijdschr Geneeskd; 1974 Dec; 118(50):1895-8. PubMed ID: 4612385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.